UE integrates R&D, manufacturing, sales, and after-sales service.
Our products are CE, FDA, South Korea KFDA, and CFDA approved and have complied with local regulatory requirements from COME in Iran and ANVISA in Brazil.

Commitment: Empower doctors to save lives
We have strived to develop and enhance our products to empower anesthesiologists to convey a sense of expertise in all possible conditions, being fully aware that anesthesiologists race against time to save lives, and the primary step is tracheal intubations in a few precious seconds.

3 R&D centers in LA, US and Shenzhen and Hangzhou, China
2 sales centers in Boston, US and Shanghai, China
Around 150 remarkable R&D professionals are collaborating with eminent clinical experts, scientific research institutes, and top universities worldwide. We have been delivering innovative solutions based on clinical needs and feedback.


By the end of 2019, we have:
Global
sold to 5 continents (Countries and regions including the US, Germany, Italy, Netherlands, South Korea, etc.)
By the end of 2019, we have:
China
accounted for over 80% market share
covered 6,000+ medium and large hospitals
covered 80% of Tier 3 hospitals (top 1,400+)
prepared 10,000+ out of 90,000+ anesthesiologists for intubation
We're UE
29 M
Annual turnover (USD)
35 %
Growth/year
10
Years in business
500 +
Employees
28 %
R&D
Our locations